Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127671141 | 12767114 | 1 | I | 201602 | 20160919 | 20160921 | 20160921 | EXP | US-PFIZER INC-2016439818 | PFIZER | 50.00 | YR | F | Y | 0.00000 | 20160921 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127671141 | 12767114 | 1 | PS | Genotropin MQ | SOMATROPIN | 1 | 0.6 MG, DAILY | 20280 | .6 | MG | POWDER FOR SOLUTION FOR INJECTION | ||||||||
| 127671141 | 12767114 | 2 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 127671141 | 12767114 | 3 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 127671141 | 12767114 | 4 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 127671141 | 12767114 | 5 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 127671141 | 12767114 | 6 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | 70 MG, UNK | 0 | 70 | MG | |||||||||
| 127671141 | 12767114 | 7 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 127671141 | 12767114 | 8 | C | BUPROPION. | BUPROPION | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
| 127671141 | 12767114 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 127671141 | 12767114 | 10 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | UNK | 0 | |||||||||||
| 127671141 | 12767114 | 11 | C | CLONAZEPAM. | CLONAZEPAM | 1 | UNK | 0 | |||||||||||
| 127671141 | 12767114 | 12 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 100 MG, UNK | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127671141 | 12767114 | 1 | Blood growth hormone |
| 127671141 | 12767114 | 2 | Depression |
| 127671141 | 12767114 | 3 | Blood cholesterol |
| 127671141 | 12767114 | 4 | Depression |
| 127671141 | 12767114 | 5 | Sleep disorder |
| 127671141 | 12767114 | 6 | Osteoporosis |
| 127671141 | 12767114 | 7 | Depression |
| 127671141 | 12767114 | 8 | Depression |
| 127671141 | 12767114 | 9 | Blood pressure abnormal |
| 127671141 | 12767114 | 10 | Neck pain |
| 127671141 | 12767114 | 11 | Anxiety |
| 127671141 | 12767114 | 12 | Sleep disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127671141 | 12767114 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127671141 | 12767114 | Malignant pituitary tumour | |
| 127671141 | 12767114 | Salivary gland neoplasm |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127671141 | 12767114 | 4 | 2016 | 0 |